🇺🇸 Calcium carbonate D in United States

16 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Urinary Tract Infection — 3 reports (18.75%)
  2. Asthenia — 2 reports (12.5%)
  3. Fatigue — 2 reports (12.5%)
  4. Nausea — 2 reports (12.5%)
  5. Tremor — 2 reports (12.5%)
  6. Abdominal Hernia — 1 report (6.25%)
  7. Abdominal Pain — 1 report (6.25%)
  8. Abdominal Pain Lower — 1 report (6.25%)
  9. Anaemia — 1 report (6.25%)
  10. Arthralgia — 1 report (6.25%)

Source database →

Calcium carbonate D in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Calcium carbonate D approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Calcium carbonate D in United States?

Peking University People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.